HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macrophage activation syndrome after etanercept treatment.

AuthorsCharanjit Sandhu, Alden Chesney, Eugenia Piliotis, Rena Buckstein, Sharon Koren
JournalThe Journal of rheumatology (J Rheumatol) Vol. 34 Issue 1 Pg. 241-2 (Jan 2007) ISSN: 0315-162X [Print] Canada
PMID17216706 (Publication Type: Case Reports, Letter)
Chemical References
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept
Topics
  • Adult
  • Antirheumatic Agents (adverse effects)
  • Arthritis, Rheumatoid (drug therapy)
  • Bone Marrow (pathology)
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (adverse effects)
  • Lymphohistiocytosis, Hemophagocytic (chemically induced, diagnosis, pathology)
  • Macrophage Activation (drug effects)
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: